• Casey LC, Balk RA & Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771778.
  • Farber BF & Wolff AG (1992) The use of nonsteroidal anti-inflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers. J Infect Dis 166: 861865.
  • Greene C, McDevitt D, Francois P, Vaudaux PE, Lew DP & Foster TJ (1995) Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol Microbiol 17: 11431152.
  • Gustafson JE, Candelaria PV, Fisher SA, Goodridge JP, Lichocik TM, McWilliams TM, Price CT, O'Brien FG & Grubb WB (1999) Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 43: 990992.
  • Hamill RJ, Vann JM & Proctor RA (1986) Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun 54: 833836.
  • Khosrovaneh A, Riederer K, Saeed S, Tabriz MS, Shah AR, Hanna MM, Sharma M, Johnson LB, Fakih MG & Khatib R (2004) Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 38: 13281330.
  • Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG & Bayer AS (1999) Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 99: 27912797.
  • Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong YQ, Palma M, Cheung AL & Bayer AS (2003) Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 112: 222233.
  • Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520532.
  • Needs CJ & Brooks PM (1985) Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10: 164177.
  • Ogawa SK, Yurberg ER, Hatcher VB, Levitt MA & Lowy FD (1985) Bacterial adherence to human endothelial cells in vitro. Infect Immun 50: 218224.
  • Peacock SJ, Foster TJ, Cameron BJ & Berendt AR (1999) Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 145: 34773486.
  • Schwarz-Linek U, Werner JM, Pickford AR et al. (2003) Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 423: 177181.
  • Soderquist B, Alriksson I, Kallman J & Kihlstrom E (2006) The influence of adhesive and invasive properties of Staphylococcus aureus defective in fibronectin-binding proteins on secretion of interleukin-6 by human endothelial cells. APMIS 114: 112116.
  • Strindhall J, Lindgren PE, Lofgren S & Kihlstrom E (2005) Clinical isolates of Staphylococcus aureus vary in ability to stimulate cytokine expression in human endothelial cells. Scand J Immunol 61: 5762.
  • Van Belkum A, Kools-Sijmons M & Verbrugh H (2002) Attachment of Staphylococcus aureus to eukaryotic cells and experimental pitfalls in staphylococcal adherence assays: a critical appraisal. J Microbiol Methods 48: 1942.
  • Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM & Proctor RA (1996) Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 173: 739742.
  • Von Eiff C, Becker K, Metze D, Lubritz G, Hockmann J, Schwarz T & Peters G (2001) Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis 32: 16431647.
  • Yao L, Bengualid V, Lowy FD, Gibbons JJ, Hatcher VB & Berman JW (1995) Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun 63: 18351839.